Rosamund Vallings
Research Subjects
Rosamund Vallings has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Alex Noble
Department of Biochemistry, University of Otago, Dunedin 9016, New Zealand
1 shared publication - Amber Helliwell
Department of Biochemistry, University of Otago, Dunedin 9016, New Zealand
1 shared publication - Angus Mackay
The Brain Health Research Centre, University of Otago, Dunedin, New Zealand
1 shared publication - Christina D. Edgar
Department of Biochemistry, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin 9054, New Zealand
1 shared publication - Eiren Sweetman
Department of Biochemistry, University of Otago, Dunedin, 9016, New Zealand
1 shared publication - Margaret M. Ryan
Department of Anatomy, School of Biomedical Sciences, University of Otago, PO Box 56, Dunedin, New Zealand; Brain Health Research Centre, University of Otago, Dunedin, New Zealand
1 shared publication
Latest Publications
- Open Access
- 30 September 2022
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 14 (3) , 283-284
‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
- 30 September 2022
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 14 (3) , 283-284
Open Access‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
- Open Access
- 18 December 2019
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 11 (4) , 295-299
Chronic fatigue syndrome
- 18 December 2019
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 11 (4) , 295-299
Open AccessChronic fatigue syndrome
- Open Access
- 10 July 2019
- Published by MDPI AG in Diagnostics
- Vol. 9 (3) , 73
Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe fatigue illness that occurs most commonly following a viral infection, but other physiological triggers are also implicated. It has a profound long-term impact on the life of the affected person. ME/CFS is diagnosed primarily by the exclusion of other fatigue illnesses, but the availability of multiple case definitions for ME/CFS has complicated diagnosis for clinicians. There has been ongoing controversy over the nature of ME/CFS, but a recent detailed report from the Institute of Medicine (Academy of Sciences, USA) concluded that ME/CFS is a medical, not psychiatric illness. Importantly, aspects of the biological basis of the ongoing disease have been revealed over the last 2–3 years that promise new leads towards an effective clinical diagnostic test that may have a general application. Our detailed molecular studies with a preclinical study of ME/CFS patients, along with the complementary research of others, have reported an elevation of inflammatory and immune processes, ongoing neuro-inflammation, and decreases in general metabolism and mitochondrial function for energy production in ME/CFS, which contribute to the ongoing remitting/relapsing etiology of the illness. These biological changes have generated potential molecular biomarkers for use in diagnostic ME/CFS testing.
- 10 July 2019
- Published by MDPI AG in Diagnostics
- Vol. 9 (3) , 73
Open AccessCurrent Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe fatigue illness that occurs most commonly following a viral infection, but other physiological triggers are also implicated. It has a profound long-term impact on the life of the affected person. ME/CFS is diagnosed primarily by the exclusion of other fatigue illnesses, but the availability of multiple case definitions for ME/CFS has complicated diagnosis for clinicians. There has been ongoing controversy over the nature of ME/CFS, but a recent detailed report from the Institute of Medicine (Academy of Sciences, USA) concluded that ME/CFS is a medical, not psychiatric illness. Importantly, aspects of the biological basis of the ongoing disease have been revealed over the last 2–3 years that promise new leads towards an effective clinical diagnostic test that may have a general application. Our detailed molecular studies with a preclinical study of ME/CFS patients, along with the complementary research of others, have reported an elevation of inflammatory and immune processes, ongoing neuro-inflammation, and decreases in general metabolism and mitochondrial function for energy production in ME/CFS, which contribute to the ongoing remitting/relapsing etiology of the illness. These biological changes have generated potential molecular biomarkers for use in diagnostic ME/CFS testing.
- 26 October 2009
- Published by BMJ in Journal of Clinical Pathology
- Vol. 63 (2) , 184-185
A case of chronic fatigue syndrome triggered by influenza H1N1 (swine influenza)
This case report describes an adolescent boy who was diagnosed as suffering from chronic fatigue syndrome 5 months after infection with H1N1 influenza.
- 26 October 2009
- Published by BMJ in Journal of Clinical Pathology
- Vol. 63 (2) , 184-185
A case of chronic fatigue syndrome triggered by influenza H1N1 (swine influenza)
This case report describes an adolescent boy who was diagnosed as suffering from chronic fatigue syndrome 5 months after infection with H1N1 influenza.